S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

Stopped early · Phase 3

Conditions studied: Bladder Cancer

In brief

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. It is not yet known whether ciprofloxacin is more effective than cephalexin in preventing cancer recurrence in patients who are undergoing surgery to treat bladder cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of ciprofloxacin with that of cephalexin in preventing recurrence of cancer in patients who are undergoing surgery for bladder cancer.

Key facts

Study ID
NCT00003824
Run by
SWOG Cancer Research Network
People needed
114
Starts
1999-04-01
Expected to finish
2007-01-01
Last updated by the study team
2012-03-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.